{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:47:22Z","timestamp":1783720042267,"version":"3.55.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.trecan.2017.12.001","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T21:16:06Z","timestamp":1513804566000},"page":"167-169","source":"Crossref","is-referenced-by-count":4,"title":["Exploring Stem Cell Heterogeneity in Chronic Myeloid Leukemia"],"prefix":"10.1016","volume":"4","author":[{"given":"Chinmay","family":"Munje","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mhairi","family":"Copland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2017.12.001_bib0005","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.hoc.2011.09.001","article-title":"Hurdles toward a cure for CML: the CML stem cell","volume":"25","author":"Gallipoli","year":"2011","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.trecan.2017.12.001_bib0010","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial","volume":"11","author":"Mahon","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.trecan.2017.12.001_bib0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3324\/haematol.2010.035006","article-title":"CD34+\/CD38\u2212 stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab\/ozogamicin","volume":"97","author":"Herrmann","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.trecan.2017.12.001_bib0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nature13600","article-title":"Clonal evolution in breast cancer revealed by single nucleus genome sequencing","volume":"512","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2017.12.001_bib0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13059-016-0945-9","article-title":"Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma","volume":"17","author":"Kim","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.trecan.2017.12.001_bib0030","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa0763","article-title":"Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia","volume":"7","author":"Paguirigan","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.trecan.2017.12.001_bib0035","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nm.4336","article-title":"Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia","volume":"23","author":"Giustacchini","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2017.12.001_bib0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nprot.2014.006","article-title":"Full-length RNA-seq from single cells using Smart-seq2","volume":"9","author":"Picelli","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.trecan.2017.12.001_bib0045","first-page":"2579","article-title":"Visualizing data using t-SNE","volume":"9","author":"van der Maaten","year":"2008","journal-title":"J. Mach. Learn. Res."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803317302327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803317302327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T00:58:22Z","timestamp":1535158702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803317302327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S2405803317302327"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2017.12.001","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}